Impax Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-13,996
| Closed | -$892K | – | 188 |
|
|
2017
Q3 | $892K | Buy |
13,996
+1,000
| +8% | +$63.7K | 0.05% | 148 |
|
|
2017
Q2 | $724K | Buy |
12,996
+1,200
| +10% | +$66.9K | 0.04% | 148 |
|
|
2017
Q1 | $641K | Buy |
11,796
+800
| +7% | +$43.5K | 0.04% | 154 |
|
|
2016
Q4 | $643K | Buy |
10,996
+400
| +4% | +$23.4K | 0.04% | 152 |
|
|
2016
Q3 | $571K | Sell |
10,596
-4,812
| -31% | -$259K | 0.03% | 151 |
|
|
2016
Q2 | $1.13M | Sell |
15,408
-40,300
| -72% | -$2.96M | 0.07% | 140 |
|
|
2016
Q1 | $3.56M | Buy |
55,708
+1,361
| +3% | +$87K | 0.19% | 117 |
|
|
2015
Q4 | $3.74M | Buy |
54,347
+5,229
| +11% | +$360K | 0.21% | 109 |
|
|
2015
Q3 | $2.91M | Sell |
49,118
-4,717
| -9% | -$279K | 0.17% | 113 |
|
|
2015
Q2 | $3.58M | Buy |
53,835
+932
| +2% | +$62K | 0.19% | 116 |
|
|
2015
Q1 | $3.41M | Buy |
52,903
+282
| +0.5% | +$18.2K | 0.19% | 116 |
|
|
2014
Q4 | $3.11M | Buy |
52,621
+5,760
| +12% | +$340K | 0.18% | 113 |
|
|
2014
Q3 | $2.4M | Buy |
46,861
+41,481
| +771% | +$2.12M | 0.16% | 118 |
|
|
2014
Q2 | $261K | Buy |
+5,380
| New | +$261K | 0.02% | 180 |
|